Creating intelligent diagnosis and treatment standards for children and adolescents with mental disorders
To Develop Intelligent Warning, Diagnosis and Intervention Systems for Children and Adolescents With Mental Disorders and Developmental Behavioral Disorders
This study is trying to find out how common mental health issues are in kids and teens in China to create better ways to diagnose and treat them.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 12000 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Children's Hospital of Chongqing Medical University Academic / other |
| Locations | 1 site (Chongqing, Chongqing) |
| Trial ID | NCT06155201 on ClinicalTrials.gov |
What this trial studies
This study aims to address the rising prevalence of mental disorders among children and adolescents in the Sichuan-Chongqing region of China. It will conduct a multi-center epidemiological survey to assess the prevalence and characteristics of conditions such as depressive disorders, anxiety disorders, autism spectrum disorders, and attention deficit hyperactivity disorder. The study will involve over 12,000 participants under 18 years old, using DSM-5 criteria for diagnosis. Researchers will develop an intelligent diagnosis and treatment system based on the collected data, aiming to improve early identification and intervention strategies for these mental health issues.
Who should consider this trial
Good fit: Ideal candidates include children and adolescents under 18 years old diagnosed with depressive disorders, anxiety disorders, autism spectrum disorders, or ADHD.
Not a fit: Patients with other mental illnesses, neurological disorders, or severe physical illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early diagnosis and treatment options for children and adolescents with mental disorders.
How similar studies have performed: Other studies have shown promise in developing intelligent diagnostic systems for mental health, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Depression patients:(1)Diagnose of depression according to DSM-5;Having the ability to act independently;Clear awareness;Able to communicate normally;Consent to the study ; (2)Under 18 years old; * Anxiety patients: (1)Diagnose of anxiety according to DSM-5;Having the ability to act independently;Clear awareness;Able to communicate normally;Consent to the study ; (2)Under 18 years old; * ASD patients:(1) Diagnose of ASD according to DSM-5;Do not have other neurological developmental disorders; (2)Under 18 years old; * ADHD patients: (1) Diagnose of ADHD according to DSM-5;Do not have other neurological developmental disorders; (2)Aged 4-18 years old; Exclusion Criteria: * suffering other mental illnesses and neurological disorders now or in the past * suffering severe physical illnesses now or in the past * substance or drug abuse now or in the past
Where this trial is running
Chongqing, Chongqing
- Growth,Development and Mental Health of Children and Adolescents Center — Chongqing, Chongqing, China (Recruiting)
Study contacts
- Study coordinator: Li Chen, doctor
- Email: chenli2012@126.com
- Phone: 13677620103
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.